Abstract
5-(7-Methyl-2-propyl-1H-benzo[d]imidazol-5-yl)-4-phenyl-4H-1,2,4-triazole-3-thiols (6a-i) have been synthesized from key intermediate 7-methyl-2-propyl-1H-benzo[d]imidazole-5- carbohydrazide(3). The hydrazide was treated with different aryl isothiocyanates to give corresponding thiosemicarbazone derivatives, which underwent cyclization in 4N sodium hydroxide to afford the corresponding title compound. All the compounds were evaluated for their in vitro antioxidant and in vivo anti-inflammatory activity. From the results, compounds 6b and 6e showed potential antioxidant and anti-inflammatory activity. The biological data was further supported by molecular docking studies, which revealed the binding pattern and the affinity of the molecules in the active site of COX-2.
Keywords: Benzimidazolyl-1, 2, 4-triazole, antioxidant activity, anti-inflammatory activity, in silico studies.
Graphical Abstract
Letters in Organic Chemistry
Title:Design, Synthesis, Antioxidant, Anti-inflammatory Activity and Molecular Docking Studies of Novel 3,4,5-Trisubstituted-1,2,4-Triazole Derivatives Bearing Benzimidazole Moiety
Volume: 18 Issue: 9
Author(s): Ramamurthy Katikireddy, Ramu Kakkerla*, M.P.S.Murali Krishna, Gandamalla Durgaiah and Narasimha Reddy Yellu
Affiliation:
- Department of Chemistry, Satavahana University, Karimnagar, Telangana State-505001,India
Keywords: Benzimidazolyl-1, 2, 4-triazole, antioxidant activity, anti-inflammatory activity, in silico studies.
Abstract: 5-(7-Methyl-2-propyl-1H-benzo[d]imidazol-5-yl)-4-phenyl-4H-1,2,4-triazole-3-thiols (6a-i) have been synthesized from key intermediate 7-methyl-2-propyl-1H-benzo[d]imidazole-5- carbohydrazide(3). The hydrazide was treated with different aryl isothiocyanates to give corresponding thiosemicarbazone derivatives, which underwent cyclization in 4N sodium hydroxide to afford the corresponding title compound. All the compounds were evaluated for their in vitro antioxidant and in vivo anti-inflammatory activity. From the results, compounds 6b and 6e showed potential antioxidant and anti-inflammatory activity. The biological data was further supported by molecular docking studies, which revealed the binding pattern and the affinity of the molecules in the active site of COX-2.
Export Options
About this article
Cite this article as:
Katikireddy Ramamurthy , Kakkerla Ramu *, Krishna M.P.S.Murali, Durgaiah Gandamalla and Yellu Reddy Narasimha , Design, Synthesis, Antioxidant, Anti-inflammatory Activity and Molecular Docking Studies of Novel 3,4,5-Trisubstituted-1,2,4-Triazole Derivatives Bearing Benzimidazole Moiety, Letters in Organic Chemistry 2021; 18 (9) . https://dx.doi.org/10.2174/1570178617999201014164403
DOI https://dx.doi.org/10.2174/1570178617999201014164403 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Treatment of HCV-Related Mixed Cryoglobulinemia
Current Drug Targets Imiquimod 5% Cream Use in Dermatology, Side Effects and Recent Patents
Recent Patents on Inflammation & Allergy Drug Discovery Jak2 and Reactive Oxygen Species: A Complex Relationship
Current Chemical Biology FKBP Ligands as Novel Therapeutics for Neurological Disorders
Mini-Reviews in Medicinal Chemistry How to Manage the Risk of Colorectal Cancer in Ulcerative Colitis
Current Drug Targets Ribozymes in the Age of Molecular Therapeutics
Current Molecular Medicine Driving Cellular Plasticity and Survival Through the Signal Transduction Pathways of Metabotropic Glutamate Receptors
Current Neurovascular Research Toward a Design of Affordable, Topical Microbicides: Acylcarnitine Analogues
Current Pharmaceutical Design Importance of Influx and Efflux Systems and Xenobiotic Metabolizing Enzymes in Intratumoral Disposition of Anticancer Agents
Current Cancer Drug Targets Pitavastatin and 4-Hydroxy-3-Methoxyacetophenone (HMAP) Reduce Cognitive Dysfunction in Vascular Dementia During Experimental Diabetes
Current Neurovascular Research Mechanism and Inhibition of Matrix Metalloproteinases
Current Medicinal Chemistry Proteasome Inhibitors in Cancer Therapy
Current Drug Targets Immune System, Cell Senescence, Aging and Longevity - Inflamm-Aging Reappraised
Current Pharmaceutical Design Lipid Nanoparticles to Deliver miRNA in Cancer
Current Pharmaceutical Biotechnology Patterns of Self-Medication with Medicinal Plants and Related Adverse Events - A South American Survey
Current Drug Safety Prognostic Biomarkers of Cutaneous Malignancies – Serological, Immunohistochemical and Proteomic Approaches
Current Cancer Therapy Reviews 1, 25(OH)<sub>2</sub>D<sub>3</sub> Inhibits Hepatocellular Carcinoma Development Through Reducing Secretion of Inflammatory Cytokines from Immunocytes
Current Medicinal Chemistry BRCA Unclassified Variants: How Can They be Classified?
Current Women`s Health Reviews Overview on Inhalable Nanocarriers for Respiratory Immunization
Current Pharmaceutical Design QSAR of Pyrazole Oxadiazole Derivatives as s1p1 Agonists Studied by CoMFA, CoMSIA and Docking
Letters in Drug Design & Discovery